查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994748

2026年全球基因治療釋放檢測市場報告

Release Testing For Gene Therapy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基因治療上市試驗市場發展迅速。預計該市場規模將從2025年的14.3億美元成長到2026年的16.7億美元，複合年成長率（CAGR）為16.3%。過去幾年成長要素包括基因治療臨床試驗數量的增加、監管品質標準的嚴格提高、病毒載體生產的擴大、生技藥品檢測實驗室數量的增加以及先進醫療技術核准數量的上升。

預計未來幾年基因治療產品放行檢測市場將快速成長，到2030年將達到30.8億美元，複合年成長率（CAGR）為16.5%。預測期內的成長預計將受到以下因素的推動：商業基因治療的擴張、對快速出貨前檢測需求的增加、合約檢測服務的擴展、監管力度的加強以及自動化品管平台的應用。預測期內的關鍵趨勢包括：高靈敏度療效檢測、快速無菌檢測平台、自動化大量出貨分析、多參數品管以及先進的載體鑑定檢測。

全球基因療法核准數量的不斷成長預計將推動基因療法上市試驗市場的發展。基因療法是一種醫療實踐，涉及在患者細胞內引入、移除或修改遺傳物質，以治療或預防疾病。全球基因療法核准的成長得益於監管機構日益成長的認可、持續的科學進步以及對以往難以治療的遺傳疾病創新治療方法的需求不斷增加。基因療法上市試驗是監管機構為確保產品品質和病人安全而製定的必要程序，旨在批次放行前評估其效力、純度、鑑別和安全性。例如，根據美國政府研究機構國家生物技術資訊中心（NCBI）的數據，截至2023年11月，全球已有超過100種基因療法、細胞療法和核糖核酸（RNA）療法獲得核准，另有超過3700種治療方法處於臨床和臨床前開發階段。因此，全球基因療法核准數量的不斷成長預計將推動基因療法上市試驗市場的發展。

基因治療產品放行檢測市場的主要企業正致力於開發創新解決方案，例如基於數位PCR的分析檢測平台，以滿足日益成長的對高精度、高靈敏度和標準化檢測方法的需求，從而確保複雜基因治療產品的安全性、有效性和合規性。基於數位聚合酵素鏈鎖反應（PCR）的分析檢測平台是一種先進的分子系統，它透過將樣本分成數千個獨立的反應，精確量化去氧核糖核酸（DNA）或核糖核酸（RNA），從而實現對核酸標靶的超靈敏和絕對測量。例如，2025年4月，總部位於德國的分子診斷和生命科學工具供應商凱傑公司（QIAGEN NV）擴展了其QIAcuity數位PCR產品組合，新增了旨在增強細胞和基因治療生產品管的慢病毒解決方案。這些新增產品支援病毒載體的基因組滴度測定、載體拷貝數測量以及具有複製能力的慢病毒檢測，從而為製程開發、批次放行和合規性檢測提供高精度分析。該平台提供專門設計的試劑盒，用於單重和多重應用中的絕對定量、高重複性和關鍵基因治療載體，與許多傳統檢測方法相比，可提供更可靠、更可重複的結果。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球基因治療產品上市檢測市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 活性成分的高靈敏度定量分析
    • 快速無菌檢測平台
    • 自動化批次放行分析
    • 多項品管面板
    • 高級向量識別測試

第5章 終端用戶產業市場分析

  • 製藥公司
  • 生技公司
  • 合約研究機構
  • 學術研究機構
  • 基因治療開發公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球基因療法產品放行檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球基因治療藥物釋放檢測市場規模、對比及成長率分析
  • 全球基因治療產品上市檢測市場表現：規模與成長，2020-2025年
  • 全球基因治療產品放行檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 測試類型
  • 效能試驗、純度試驗、鑑別試驗、安全性試驗、無菌試驗及其他試驗類型
  • 依產品類型
  • 檢測試劑盒、試劑、儀器及服務
  • 透過治療方法
  • 體內基因治療，體外基因治療
  • 透過使用
  • 臨床診斷、研究、品管、製程開發及其他應用
  • 最終用戶
  • 製藥和生物技術公司、學術和研究機構、受託研究機構以及其他最終用戶
  • 按類型細分：療效試驗
  • 功能活性測定、基因表現量測量、生物活性評估、劑量反應評估。
  • 按類型細分：純度測試
  • 殘留宿主細胞蛋白分析、殘留去氧核糖核酸定量、製程相關雜質檢測、產品相關雜質評估。
  • 按類型細分：身分識別測試
  • 基因序列驗證、載體身份驗證、基因改造身份分析、細胞株真實性驗證。
  • 按類型細分：安全測試
  • 外來性因素檢測、病毒複製能力檢測、內毒素濃度評估、毒性評估。
  • 按類型細分：無菌檢測
  • 細菌污染檢測、真菌污染檢測、黴漿菌檢測和環境監測的驗證。
  • 按類型細分：其他測試類型
  • 穩定性測試、包裝完整性測試、保存期限測定和運輸/儲存條件測試。

第10章 區域與國別分析

  • 全球基因治療產品放行檢測市場：依地區分類，實際結果及預測，2020-2025年、2025-2030年、2035年
  • 全球基因療法產品放行檢測市場：依國家分類，實際結果及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 基因療法產品上市檢測市場：競爭格局及市場佔有率（2024年）
  • 基因治療產品上市檢測市場：公司評估矩陣
  • 基因治療藥物釋放檢測市場：公司概況
    • Thermo Fisher Scientific Inc.
    • Boehringer Ingelheim BioXcellence GmbH
    • Fujifilm Diosynth Biotechnologies Inc.
    • AGC Biologics Inc.
    • SGS SA

第37章 其他大型企業和創新企業

  • Lonza Group AG, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius AG, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Pace Analytical Services LLC, KBI Biopharma Inc., BioAgilytix Labs LLC, Viralgen Vector SL, GenScript ProBio LLC, KCAS Bioanalytical Services, Creative Biolabs LLC, Cellipont Bioservices Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章：預計進入市場的Start-Ups

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年基因療法釋放檢測市場：提供新機會的國家
  • 2030年基因療法產品上市檢測市場：新興細分市場機會
  • 2030年基因療法釋放檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: PS5MRTGT01_G26Q1

Release testing for gene therapy is a quality assurance procedure performed to verify that gene therapy products meet established safety, effectiveness, purity, and identity requirements before patient use. It ensures that gene therapy treatments are safe, reliable, and compliant with regulatory standards for clinical and commercial application.

The primary types of release testing for gene therapy include potency testing, purity testing, identity testing, safety testing, sterility testing, and other test types. Potency testing refers to procedures used to evaluate the biological activity of gene therapy products to ensure effectiveness and consistency. These tests are conducted for product types including assay kits, reagents, instruments, and services. They are used for therapy types such as in vivo gene therapy and ex vivo gene therapy. They are applied across applications including clinical diagnostics, research, quality control, process development, and other applications, and are utilized by end users including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and other end users.

Tariffs are impacting the release testing for gene therapy market by increasing the cost of imported assay kits, analytical instruments, and specialized reagents. Higher duties are raising operational costs across potency, purity, and safety testing segments. Contract research organizations and biotech manufacturers that depend on imported testing systems are most affected. Regions relying on global laboratory equipment supply chains, especially in asia pacific and europe, are experiencing procurement delays. Testing providers are moving toward regional suppliers and localized sourcing strategies. Tariffs are also encouraging domestic production of test kits and analytical tools. This supports local laboratory supply ecosystems and strengthens long term testing capacity.

The release testing for gene therapy market research report is one of a series of new reports from The Business Research Company that provides release testing for gene therapy market statistics, including release testing for gene therapy industry global market size, regional shares, competitors with a release testing for gene therapy market share, detailed release testing for gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the release testing for gene therapy industry. This release testing for gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The release testing for gene therapy market size has grown rapidly in recent years. It will grow from $1.43 billion in 2025 to $1.67 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to rise in gene therapy trials, strict regulatory quality standards, growth in viral vector production, expansion of biologics testing labs, increase in advanced therapy approvals.

The release testing for gene therapy market size is expected to see rapid growth in the next few years. It will grow to $3.08 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to growth in commercial gene therapies, rising demand for rapid release testing, expansion of contract testing services, increasing regulatory scrutiny, adoption of automated qc platforms. Major trends in the forecast period include high sensitivity potency assays, rapid sterility testing platforms, automated batch release analytics, multi parameter quality control panels, advanced vector identity testing.

The rising number of global approvals for gene therapies is expected to fuel the growth of the release testing for gene therapy market going forward. Gene therapies are medical treatments that involve the introduction, removal, or modification of genetic material within a patient's cells to treat or prevent disease. Growth in global gene therapy approvals is supported by increasing regulatory acceptance, ongoing scientific advancements, and rising demand for innovative treatments targeting previously untreatable genetic disorders. Release testing for gene therapy is a regulatory requirement that ensures product quality and patient safety through evaluations of potency, purity, identity, and safety prior to batch release. For instance, in November 2023, according to the National Center for Biotechnology Information, a U.S.-based governmental research resource, more than 100 gene, cell, and ribonucleic acid (RNA) therapies had been approved globally as of early 2023, with over 3,700 additional therapies in clinical and preclinical development. Therefore, the increasing number of global gene therapy approvals is expected to support the growth of the release testing for gene therapy market.

Leading companies operating in the release testing for gene therapy market are focusing on developing innovative solutions, such as digital PCR-based analytical testing platforms, to address the growing need for highly accurate, sensitive, and standardized methods that ensure product safety, potency, and regulatory compliance for complex gene therapy products. Digital polymerase chain reaction (PCR)-based analytical testing platforms are advanced molecular systems that precisely quantify deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) by partitioning samples into thousands of individual reactions, enabling highly sensitive and absolute measurement of nucleic acid targets. For example, in April 2025, QIAGEN N.V., a Germany-based provider of molecular diagnostics and life science tools, expanded its QIAcuity digital PCR portfolio with new lentivirus solutions designed to enhance quality control in cell and gene therapy manufacturing. These additions support viral vector genome titration, vector copy number determination, and replication-competent lentivirus detection, enabling high-precision analytics for process development, batch release, and regulatory compliance. The platform offers absolute quantification across singleplex and multiplex applications, strong repeatability, and tailored kits for critical gene therapy vectors, providing more reliable and reproducible results than many conventional testing approaches.

In January 2026, bioMerieux S.A., a France-based biotechnology company, acquired Accellix Inc. for approximately $41 million (€35 million). With this acquisition, bioMerieux aimed to strengthen and expand its pharmaceutical quality control portfolio particularly in rapid, automated flow cytometry solutions for cell and gene therapy manufacturing to support the growing advanced therapies market and improve testing capabilities across the therapy development lifecycle. Accellix Inc. is a US-based quality control technology provider that enables rapid, automated flow cytometry-based release testing for cell and gene therapies, specifically supporting critical release parameters such as cell purity and viability.

Major companies operating in the release testing for gene therapy market are Thermo Fisher Scientific Inc., Boehringer Ingelheim BioXcellence GmbH, Fujifilm Diosynth Biotechnologies Inc., AGC Biologics Inc., SGS SA, Lonza Group AG, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius AG, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Pace Analytical Services LLC, KBI Biopharma Inc., BioAgilytix Labs LLC, Viralgen Vector S.L., GenScript ProBio LLC, KCAS Bioanalytical Services, Creative Biolabs LLC, Cellipont Bioservices Inc.

North America was the largest region in the release testing for gene therapy in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the release testing for gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the release testing for gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The release testing for gene therapy market includes revenues earned by entities through the quality control and analytical testing services, stability assessment, method validation, regulatory compliance testing, and batch release support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Release Testing For Gene Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses release testing for gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for release testing for gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The release testing for gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Potency Testing; Purity Testing; Identity Testing; Safety Testing; Sterility Testing; Other Test Types
  • 2) By Product Type: Assay Kits; Reagents; Instruments; Services
  • 3) By Therapy Type: In Vivo Gene Therapy; Ex Vivo Gene Therapy
  • 4) By Application: Clinical Diagnostics; Research; Quality Control; Process Development; Other Applications
  • 5) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Contract Research Organizations; Other End-Users
  • Subsegments:
  • 1) By Potency Testing: Functional Activity Assays; Gene Expression Level Measurement; Biological Activity Evaluation; Dose Response Assessment
  • 2) By Purity Testing: Residual Host Cell Protein Analysis; Residual Deoxyribonucleic Acid Quantification; Process Related Impurity Testing; Product Related Impurity Assessment
  • 3) By Identity Testing: Genetic Sequence Confirmation; Vector Identity Verification; Transgene Identity Analysis; Cell Line Authentication
  • 4) By Safety Testing: Adventitious Agent Testing; Replication Competent Virus Detection; Endotoxin Level Evaluation; Toxicity Assessment
  • 5) By Sterility Testing: Bacterial Contamination Testing; Fungal Contamination Testing; Mycoplasma Detection; Environmental Monitoring Validation
  • 6) By Other Test Types: Stability Testing; Packaging Integrity Testing; Shelf Life Determination; Transport and Storage Condition Testing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim BioXcellence GmbH; Fujifilm Diosynth Biotechnologies Inc.; AGC Biologics Inc.; SGS SA; Lonza Group AG; Eurofins Scientific SE; WuXi AppTec Co. Ltd.; Charles River Laboratories International Inc.; Sartorius AG; Samsung Biologics Co. Ltd.; Bio-Rad Laboratories Inc.; Pace Analytical Services LLC; KBI Biopharma Inc.; BioAgilytix Labs LLC; Viralgen Vector S.L.; GenScript ProBio LLC; KCAS Bioanalytical Services; Creative Biolabs LLC; Cellipont Bioservices Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Release Testing For Gene Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Release Testing For Gene Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Release Testing For Gene Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Release Testing For Gene Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 High Sensitivity Potency Assays
    • 4.2.2 Rapid Sterility Testing Platforms
    • 4.2.3 Automated Batch Release Analytics
    • 4.2.4 Multi Parameter Quality Control Panels
    • 4.2.5 Advanced Vector Identity Testing

5. Release Testing For Gene Therapy Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Contract Research Organizations
  • 5.4 Academic Research Institutes
  • 5.5 Gene Therapy Developers

6. Release Testing For Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Release Testing For Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Release Testing For Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Release Testing For Gene Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Release Testing For Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Release Testing For Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Release Testing For Gene Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Release Testing For Gene Therapy Market Segmentation

  • 9.1. Global Release Testing For Gene Therapy Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Potency Testing, Purity Testing, Identity Testing, Safety Testing, Sterility Testing, Other Test Types
  • 9.2. Global Release Testing For Gene Therapy Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Assay Kits, Reagents, Instruments, Services
  • 9.3. Global Release Testing For Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vivo Gene Therapy, Ex Vivo Gene Therapy
  • 9.4. Global Release Testing For Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Diagnostics, Research, Quality Control, Process Development, Other Applications
  • 9.5. Global Release Testing For Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations, Other End-Users
  • 9.6. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Potency Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Functional Activity Assays, Gene Expression Level Measurement, Biological Activity Evaluation, Dose Response Assessment
  • 9.7. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Purity Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Residual Host Cell Protein Analysis, Residual Deoxyribonucleic Acid Quantification, Process Related Impurity Testing, Product Related Impurity Assessment
  • 9.8. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Identity Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Sequence Confirmation, Vector Identity Verification, Transgene Identity Analysis, Cell Line Authentication
  • 9.9. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Safety Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adventitious Agent Testing, Replication Competent Virus Detection, Endotoxin Level Evaluation, Toxicity Assessment
  • 9.10. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Sterility Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacterial Contamination Testing, Fungal Contamination Testing, Mycoplasma Detection, Environmental Monitoring Validation
  • 9.11. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stability Testing, Packaging Integrity Testing, Shelf Life Determination, Transport and Storage Condition Testing

10. Release Testing For Gene Therapy Market Regional And Country Analysis

  • 10.1. Global Release Testing For Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Release Testing For Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Release Testing For Gene Therapy Market

  • 11.1. Asia-Pacific Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Release Testing For Gene Therapy Market

  • 12.1. China Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Release Testing For Gene Therapy Market

  • 13.1. India Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Release Testing For Gene Therapy Market

  • 14.1. Japan Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Release Testing For Gene Therapy Market

  • 15.1. Australia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Release Testing For Gene Therapy Market

  • 16.1. Indonesia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Release Testing For Gene Therapy Market

  • 17.1. South Korea Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Release Testing For Gene Therapy Market

  • 18.1. Taiwan Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Release Testing For Gene Therapy Market

  • 19.1. South East Asia Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Release Testing For Gene Therapy Market

  • 20.1. Western Europe Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Release Testing For Gene Therapy Market

  • 21.1. UK Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Release Testing For Gene Therapy Market

  • 22.1. Germany Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Release Testing For Gene Therapy Market

  • 23.1. France Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Release Testing For Gene Therapy Market

  • 24.1. Italy Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Release Testing For Gene Therapy Market

  • 25.1. Spain Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Release Testing For Gene Therapy Market

  • 26.1. Eastern Europe Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Release Testing For Gene Therapy Market

  • 27.1. Russia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Release Testing For Gene Therapy Market

  • 28.1. North America Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Release Testing For Gene Therapy Market

  • 29.1. USA Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Release Testing For Gene Therapy Market

  • 30.1. Canada Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Release Testing For Gene Therapy Market

  • 31.1. South America Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Release Testing For Gene Therapy Market

  • 32.1. Brazil Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Release Testing For Gene Therapy Market

  • 33.1. Middle East Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Release Testing For Gene Therapy Market

  • 34.1. Africa Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Release Testing For Gene Therapy Market Regulatory and Investment Landscape

36. Release Testing For Gene Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Release Testing For Gene Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Release Testing For Gene Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Release Testing For Gene Therapy Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Boehringer Ingelheim BioXcellence GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Fujifilm Diosynth Biotechnologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. AGC Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

37. Release Testing For Gene Therapy Market Other Major And Innovative Companies

  • Lonza Group AG, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius AG, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Pace Analytical Services LLC, KBI Biopharma Inc., BioAgilytix Labs LLC, Viralgen Vector S.L., GenScript ProBio LLC, KCAS Bioanalytical Services, Creative Biolabs LLC, Cellipont Bioservices Inc.

38. Global Release Testing For Gene Therapy Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Release Testing For Gene Therapy Market

41. Release Testing For Gene Therapy Market High Potential Countries, Segments and Strategies

  • 41.1 Release Testing For Gene Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Release Testing For Gene Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Release Testing For Gene Therapy Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer